By its own statement it cannot be 100% specific for ovarian cancer as other cancers produce this also. Though I gather that this trial was focused only on ovarian cancer and therefore cannot comment on specificity generally. Still amazing development though
By its own statement it cannot be 100% specific for ovarian...
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.5¢ |
Change
-0.020(3.42%) |
Mkt cap ! $62.30M | |||
| Open | High | Low | Value | Volume |
| 57.5¢ | 57.5¢ | 56.5¢ | $21.90K | 38.41K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4193 | 56.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 57.5¢ | 2000 | 1 |
View Market Depth
| Last trade - 15.33pm 11/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |